查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827766

2025年基於NGS的RNA定序全球市場報告

NGS-Based RNA-Sequencing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，基於NGS的RNA定序市場規模呈指數級成長，從2024年的34.1億美元成長到2025年的42億美元，複合年成長率為23.3%。預測期內的成長主要受基因組研究計畫、定序成本下降、藥物研發、個人化醫療以及NGS應用的不斷普及等因素所驅動。

預計未來幾年，基於NGS的RNA定序市場將呈指數級成長，到2029年將達到102.6億美元，複合年成長率為25.0%。預測期內的成長主要受臨床診斷、國際合作研究、倫理和監管框架、農業和環境研究以及綠色基因組學的推動。預測期內的主要趨勢包括單細胞RNA定序（scRNA-seq）、空間轉錄組學、表觀轉錄組學、多體學整合以及永續農業。

基於NGS的RNA定序是一種利用次世代定序儀（NGS）技術，用於識別和量化特定時刻生物樣本中核糖核酸（RNA）的含量。 NGS採用大規模平行定序技術，具有極高的通量、可擴展性和速度，可用於測定整個基因組或特定DNA/RNA片段的序列。

基於NGS的RNA定序的關鍵產品和服務包括樣品製備產品、定序平台和耗材、定序服務、數據分析、儲存和管理。樣品製備產品有助於將DNA或RNA連接到定序流動槽上，從而實現樣品鑑定。樣品製備過程將生物樣本中的核酸混合物轉化為各種文庫，並為NGS技術做好準備。 NGS涉及的技術包括邊合成邊定序、離子半導體定序、單分子即時定序和奈米孔定序。這些定序方法應用於表達譜分析、小RNA定序、從頭轉錄組組裝、變異檢測和轉錄組表觀遺傳學。基於NGS的RNA定序被各種終端用戶使用，包括研究和學術機構、醫院診所、製藥和生物技術公司以及科學界的其他營業單位。

2025年春季，美國關稅上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快研發更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供基於 NGS 的 RNA 測序市場統計數據，包括全球市場規模、各地區佔有率、競爭對手的市場佔有率、基於 NGS 的 RNA 測序細分市場、市場趨勢和商業機會，以及在基於 NGS 的 RNA 測序行業取得成功所需的其他數據。本研究報告詳細分析了基於 NGS 的 RNA 定序產業的現狀和未來趨勢，為您提供全面的觀點。

我們預測未來五年該市場將成長25.0%，較先前預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。這直接影響了美國，包括對芬蘭高保真逆轉錄酶的貿易限制，這提高了轉錄組學研究的成本，並可能減緩個人化癌症和罕見疾病治療的突破。此外，由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

精準醫療的擴張正在推動基於NGS的RNA定序市場的成長。精準醫療幫助醫療保健提供者制定個人化治療方案，並根據對患者病情的基因理解做出決策。精準醫療在治療癌症等嚴重方面日益受到關注。基於NGS的RNA定序有助於識別疾病的根本原因並建議特定的精準治療方案。例如，根據美國非營利組織個人化醫療聯盟 (PMC) 2023年2月的報告，2021年新核准的新型分子藥物 (NME) 中有35%是個人化藥物。 2022年有12個新核准，這一數字在過去八年中一直佔新藥認證的四分之一以上，與十年前不到10%的比例相比有顯著成長。隨著精準醫療需求的持續成長，基於NGS的RNA定序的需求也將隨之成長。

不斷擴張的製藥業預計將推動基於 NGS 的 RNA 測序市場的未來成長。製藥業包括公共和私人機構對藥物和藥品的發現、開發和生產。基於 NGS 的 RNA 定序用於徹底分析基因表現，識別潛在的藥物標靶，評估藥物反應，並闡明疾病機制，透過更深入地了解分子過程來增強藥物的發現和開發。例如，美國ABA 治療服務供應商 Cross River Therapy 於 2024 年 9 月發布的統計數據顯示，美國製藥業的銷售額為 5,500 億美元，美國在 2021 年的藥物支出為 5,769 億美元。預計到 2025 年，這一數字將從 6,050 億美元增至 6,350 億美元。因此，製藥業的成長正在推動基於 NGS 的 RNA 定序市場的擴張。

基於NGS的RNA定序市場的一個顯著趨勢是策略夥伴關係關係的形成。越來越多的企業與基於NGS的RNA測序公司夥伴關係，以進入新市場並利用綜合資源。例如，2022年5月，美國生物醫學高級研究與發展管理局（BARDA）與多家產學研機構合作，以加強對呼吸道RNA病毒的診斷能力。此類策略夥伴關係增強了快速應對突發公共衛生事件的能力，並有助於提高診斷能力。

基於NGS的RNA定序市場的主要企業正專注於創新產品，以滿足日益成長的RNA定序需求。其中一項創新是開發用於分子檢測和生命科學研究的超快速RNA方法，提供極快的RNA定序和分析。 2022年3月，Quantabio推出了sparQ RNA-Seq HMR Kit，這是一款專為精準腫瘤學設計的超快速RNA文庫製備工具。此套件可在一天內從完整或劣化的樣本中產生高品質的可用於NGS定序儀的文庫。

2022年10月，專注於DNA定序和晶片技術的美國公司Illumina宣布與GenoScreen建立合作關係。此次合作旨在透過擴大多重抗藥性結核病（MDR-TB）基因組檢測的可及性，以及更快速有效地檢測抗藥性，支持全球對抗結核病的鬥爭，尤其是在結核病高負擔國家。 GenoScreen是一家總部位於法國的公司，專注於定序、基因型鑒定和生物資訊學。

以 NGS 為基礎的 RNA 定序市場的主要企業包括 Illumina Inc.、Thermo Fisher Scientific Inc.、Oxford Nanopore Technologies Ltd.、Agilent Technologies Inc.、BGI Group、QIAGEN NV、PerkinElmer Inc.、Eurofins Scientific SE、Bio-Rad Laborator Inc.、F. Hmann Inc.、Eurofins Scientific SE、Bio-Rad Laborator Inc.、F. Hmann Inc. AG、GENEWIZ Inc.、Novogene Corporation、Macrogen Inc.、Zymo Research Corp.、Lexogen GmbH、Partek Incorporated、GATC BIoTech AG、Becton、Dickinson and Company、Genohub LLC、BaseClear BV、Genewave SAS、Otogenetics Corporation、GenqLL LLC、XXersPropot​​y Got​​o Got M​​T.

2024年，北美是NGS RNA定序市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。基於NGS的RNA定序市場分析報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

基於 NGS 的 RNA 定序市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

基於NGS的RNA定序市場涵蓋多種小型ncRNA（例如核醣體RNA (rRNA)、轉移RNA (tRNA)、長鏈ncRNA和微型RNA）產生的收益。市場規模還包括服務供應商銷售或包含在其服務產品中的相關商品的價值。僅包括營業單位之間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球基於NGS的RNA定序：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球基於NGS的RNA定序市場：成長率分析
  • 全球基於NGS的RNA定序市場表現：規模與成長，2019-2024年
  • 全球基於NGS的RNA定序市場預測：規模與成長，2024-2029年，2034年
  • 全球基於NGS的RNA定序：總潛在市場（TAM）

第6章 市場細分

  • 全球基於NGS的RNA定序市場（依產品與服務、績效及預測），2019-2024年、2024-2029年、2034年
  • 樣品製備產品
  • 定序平台和耗材
  • 定序服務
  • 數據分析、儲存和管理
  • 全球基於NGS的RNA定序市場（依技術、效能和預測），2019-2024年、2024-2029年和2034年
  • 邊合成邊定序
  • 離子半導體序列
  • 單分子即時定序
  • 奈米孔定序
  • 全球基於NGS的RNA定序市場（按應用、效能和預測），2019-2024年、2024-2029年和2034年
  • 表達譜分析
  • 小RNA定序
  • 從頭轉錄組組裝
  • 變異調用和轉錄組表觀遺傳學
  • 全球基於NGS的RNA定序市場（按最終用戶、表現和預測），2019-2024年、2024-2029年和2034年
  • 研究與學術
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他
  • 全球基於NGS的RNA定序市場：樣品製備產品細分，按類型、性能和預測，2019-2024年、2024-2029年、2034年
  • RNA萃取試劑套件
  • 文庫製備試劑套件
  • 逆轉錄試劑套件
  • 品管試劑
  • 全球基於 NGS 的 RNA 定序市場：定序平台和耗材細分，按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 定序設備
  • 定序耗材
  • 全球基於 NGS 的 RNA 定序市場：定序服務細分、類型、性能和預測（2019-2024 年、2024-2029 年、2034 年）
  • 合約排序服務
  • 客製化文庫製備服務
  • 諮詢和實驗設計服務
  • 全球基於NGS的RNA定序市場：資料分析、儲存和管理細分，按類型、效能和預測，2019-2024年、2024-2029年、2034年
  • 生物資訊軟體
  • 數據分析服務
  • 雲端基礎的資料儲存解決方案
  • 資料管理平台

第7章 區域和國家分析

  • 全球基於 NGS 的 RNA 定序市場：區域表現和預測（2019-2024 年、2024-2029 年和 2034 年）
  • 全球基於 NGS 的 RNA 定序市場：國家、績效及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 基於NGS的RNA定序市場：競爭格局
  • 基於NGS的RNA定序市場：公司簡介
    • Illumina Inc.
    • Thermo Fisher Scientific Inc.
    • Oxford Nanopore Technologies Ltd.
    • Agilent Technologies Inc.
    • BGI Group

第31章：其他領先和創新企業

  • QIAGEN NV
  • PerkinElmer Inc.
  • Eurofins Scientific SE
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hamilton Company
  • Takara Bio Inc.
  • Tecan Trading AG
  • GENEWIZ Inc.
  • Novogene Corporation
  • Macrogen Inc.
  • Zymo Research Corp.
  • Lexogen GmbH
  • Partek Incorporated
  • GATC BIoTech AG

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年基於NGS的RNA定序市場：提供新機會的國家
  • 2029年基於NGS的RNA定序市場：細分領域帶來新機會
  • 2029年基於NGS的RNA定序市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r21852u

NGS-based RNA-sequencing is a technique employed to identify and quantify the amount of ribonucleic acid (RNA) present in a biological sample at a specific moment, utilizing next-generation sequencing (NGS). Next-generation sequencing, characterized by massively parallel sequencing technology, offers exceptionally high throughput, scalability, and speed, allowing for the determination of nucleotide sequences in whole genomes or specific DNA/RNA segments.

The primary products and services associated with NGS-based RNA sequencing include sample preparation products, sequencing platforms and consumables, sequencing services, and data analysis, storage, & management. Sample preparation products facilitate the adherence of DNA or RNA to the sequencing flowcell, enabling sample identification. The sample preparation process involves converting nucleic acid mixtures from biological samples into various libraries, preparing them for NGS technologies. Technologies involved in NGS encompass sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing. These sequencing methods find application in expression profiling analysis, small RNA sequencing, de novo transcriptome assembly, variant calling, and transcriptome epigenetics. NGS-based RNA-sequencing is utilized by a range of end users, including research & academia, hospitals & clinics, pharmaceutical & biotechnology companies, and other entities in the scientific community.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The NGS-based RNA sequencing market research report is one of a series of new reports from The Business Research Company that provides NGS-based RNA sequencing market statistics, including NGS-based RNA sequencing industry global market size, regional shares, competitors with a NGS-based RNA sequencing market share, detailed NGS-based RNA sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the NGS-based RNA sequencing industry. This NGS-based RNA sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ngs-based rna-sequencing market size has grown exponentially in recent years. It will grow from $3.41 billion in 2024 to $4.2 billion in 2025 at a compound annual growth rate (CAGR) of 23.3%. The growth in the historic period can be attributed to genomic research initiatives, reduction in sequencing costs, drug discovery and development, personalized medicine, increasing ngs adoption.

The ngs-based rna-sequencing market size is expected to see exponential growth in the next few years. It will grow to $10.26 billion in 2029 at a compound annual growth rate (CAGR) of 25.0%. The growth in the forecast period can be attributed to clinical diagnostics, global collaborations, ethical and regulatory frameworks, agricultural and environmental research, green genomics. Major trends in the forecast period include single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, multi-omics integration, sustainable agriculture.

The forecast of 25.0% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through trade restrictions on high-fidelity reverse transcriptase enzymes from Finland, raising costs for transcriptomic research and potentially slowing breakthroughs in personalized cancer and rare disease therapies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expansion of precision medicine is propelling the growth of the NGS-based RNA sequencing market. Precision medicine assists healthcare providers in creating tailored treatment plans and making decisions based on a genetic understanding of the patient's condition. There is an increasing focus on precision medicines for addressing serious diseases such as cancer. NGS-based RNA sequencing is instrumental in identifying the underlying causes of diseases and recommending specific precision treatments. For example, in February 2023, a report from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, indicated that personalized medicines represented 35% of newly approved New Molecular Entities (NMEs) in 2021. With 12 new approvals in 2022, they have consistently accounted for at least a quarter of new drug approvals over the past eight years, marking a substantial rise from less than 10% a decade ago. As the demand for precision medicines continues to grow, so too will the demand for NGS-based RNA sequencing.

The expanding pharmaceutical industry is anticipated to drive the growth of the NGS-based RNA sequencing market in the future. The pharmaceutical industry encompasses the discovery, development, and production of drugs and medicines by both public and private organizations. NGS-based RNA sequencing is utilized within this sector to conduct thorough analyses of gene expression, identify potential drug targets, evaluate drug responses, and comprehend disease mechanisms, thereby enhancing drug discovery and development through a better understanding of molecular processes. For instance, in September 2024, statistics published by Cross River Therapy, a US-based provider of ABA therapy services, revealed that the U.S. pharmaceutical industry generated $550 billion in revenue, with Americans spending $576.9 billion on medications in 2021. Projected spending is expected to rise to between $605 billion and $635 billion by 2025. Consequently, the growth of the pharmaceutical industry is propelling the expansion of the NGS-based RNA sequencing market.

A notable trend in the NGS-based RNA sequencing market is the formation of strategic partnerships. Companies are increasingly engaging in partnerships with NGS-based RNA sequencing firms to enter new markets and leverage collective resources. For instance, in May 2022, The Biomedical Advanced Research and Development Authority (BARDA) partnered with multiple industry and academic collaborators to enhance diagnostic capabilities for respiratory RNA viruses. Such strategic partnerships contribute to bolstering the capacity to respond swiftly to public health emergencies and advance diagnostic capabilities.

Major companies in the NGS-based RNA-sequencing market are concentrating on innovative products to meet the growing demand for RNA sequencing. One such innovation is the development of ultra-fast RNA methods for molecular testing and life science research applications, offering exceptionally rapid RNA sequencing or analysis. In March 2022, Quantabio launched the sparQ RNA-Seq HMR Kit, an ultra-fast RNA library preparation tool designed for precision oncology applications. This kit enables the generation of high-quality NGS sequencer-ready libraries from intact or degraded samples in a single day.

In October 2022, Illumina Inc., a US-based company specializing in DNA sequencing and array-based technology, announced a collaboration with GenoScreen. This partnership seeks to enhance access to genomic testing for multidrug-resistant tuberculosis (MDR-TB), facilitating faster and more effective detection of drug resistance to aid in the global fight against TB, particularly in countries severely affected by the disease. GenoScreen is a France-based company focused on sequencing, genotyping, and bioinformatics.

Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in NGS-based RNA sequencing market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the NGS-based RNA sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The NGS-based RNA-sequencing market includes revenues earned by ribosomal RNA (rRNA), transfer RNA (tRNA), long ncRNA and many smaller ncRNAs such as microRNA. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

NGS-Based RNA-Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ngs-based rna-sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ngs-based rna-sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ngs-based rna-sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Service: Sample Preparation Products; Sequencing Platforms and Consumables; Sequencing Services; Data Analysis, Storage, and Management
  • 2) By Technology: Sequencing by Synthesis; Ion Semiconductor Sequencing; Single-molecule Real-time Sequencing; Nanopore Sequencing
  • 3) By Application: Expression Profiling Analysis; Small RNA Sequencing; De Novo Transcriptome Assembly; Variant Calling and Transcriptome Epigenetics
  • 4) By End User: Research & Academia; Hospitals & Clinics; Pharmaceutical & Biotechnology Companies; Other End Users
  • Subsegments:
  • 1) By Sample Preparation Products: RNA Extraction Kits; Library Preparation Kits; Reverse Transcription Kits; Quality Control Reagents
  • 2) By Sequencing Platforms And Consumables: Sequencing Instruments; Sequencing Consumables
  • 3) By Sequencing Services: Contract Sequencing Services; Custom Library Preparation Services; Consultation And Experimental Design Services
  • 4) By Data Analysis, Storage, And Management: Bioinformatics Software; Data Analysis Services; Cloud-Based Data Storage Solutions; Data Management Platforms
  • Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; Oxford Nanopore Technologies Ltd.; Agilent Technologies Inc.; BGI Group; QIAGEN N.V.; PerkinElmer Inc.; Eurofins Scientific SE; Bio-Rad Laboratories Inc.; F. Hoffmann-La Roche Ltd.; Hamilton Company; Takara Bio Inc.; Tecan Trading AG; GENEWIZ Inc.; Novogene Corporation; Macrogen Inc.; Zymo Research Corp.; Lexogen GmbH; Partek Incorporated; GATC Biotech AG; Becton, Dickinson and Company; Genohub LLC; BaseClear B.V.; Genewave SAS; Otogenetics Corporation; SeqLL LLC; GenXPro GmbH; Genotypic Technology Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. NGS-Based RNA-Sequencing Market Characteristics

3. NGS-Based RNA-Sequencing Market Trends And Strategies

4. NGS-Based RNA-Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global NGS-Based RNA-Sequencing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global NGS-Based RNA-Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global NGS-Based RNA-Sequencing Market Growth Rate Analysis
  • 5.4. Global NGS-Based RNA-Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global NGS-Based RNA-Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global NGS-Based RNA-Sequencing Total Addressable Market (TAM)

6. NGS-Based RNA-Sequencing Market Segmentation

  • 6.1. Global NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sample Preparation Products
  • Sequencing Platforms and Consumables
  • Sequencing Services
  • Data Analysis, Storage, and Management
  • 6.2. Global NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing
  • Nanopore Sequencing
  • 6.3. Global NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Expression Profiling Analysis
  • Small RNA Sequencing
  • De Novo Transcriptome Assembly
  • Variant Calling and Transcriptome Epigenetics
  • 6.4. Global NGS-Based RNA-Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research & Academia
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other End Users
  • 6.5. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sample Preparation Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • RNA Extraction Kits
  • Library Preparation Kits
  • Reverse Transcription Kits
  • Quality Control Reagents
  • 6.6. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sequencing Platforms And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Instruments
  • Sequencing Consumables
  • 6.7. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sequencing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Contract Sequencing Services
  • Custom Library Preparation Services
  • Consultation And Experimental Design Services
  • 6.8. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Data Analysis, Storage, And Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bioinformatics Software
  • Data Analysis Services
  • Cloud-Based Data Storage Solutions
  • Data Management Platforms

7. NGS-Based RNA-Sequencing Market Regional And Country Analysis

  • 7.1. Global NGS-Based RNA-Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global NGS-Based RNA-Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific NGS-Based RNA-Sequencing Market

  • 8.1. Asia-Pacific NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China NGS-Based RNA-Sequencing Market

  • 9.1. China NGS-Based RNA-Sequencing Market Overview
  • 9.2. China NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India NGS-Based RNA-Sequencing Market

  • 10.1. India NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan NGS-Based RNA-Sequencing Market

  • 11.1. Japan NGS-Based RNA-Sequencing Market Overview
  • 11.2. Japan NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia NGS-Based RNA-Sequencing Market

  • 12.1. Australia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia NGS-Based RNA-Sequencing Market

  • 13.1. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea NGS-Based RNA-Sequencing Market

  • 14.1. South Korea NGS-Based RNA-Sequencing Market Overview
  • 14.2. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe NGS-Based RNA-Sequencing Market

  • 15.1. Western Europe NGS-Based RNA-Sequencing Market Overview
  • 15.2. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK NGS-Based RNA-Sequencing Market

  • 16.1. UK NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany NGS-Based RNA-Sequencing Market

  • 17.1. Germany NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France NGS-Based RNA-Sequencing Market

  • 18.1. France NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy NGS-Based RNA-Sequencing Market

  • 19.1. Italy NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain NGS-Based RNA-Sequencing Market

  • 20.1. Spain NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe NGS-Based RNA-Sequencing Market

  • 21.1. Eastern Europe NGS-Based RNA-Sequencing Market Overview
  • 21.2. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia NGS-Based RNA-Sequencing Market

  • 22.1. Russia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America NGS-Based RNA-Sequencing Market

  • 23.1. North America NGS-Based RNA-Sequencing Market Overview
  • 23.2. North America NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA NGS-Based RNA-Sequencing Market

  • 24.1. USA NGS-Based RNA-Sequencing Market Overview
  • 24.2. USA NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada NGS-Based RNA-Sequencing Market

  • 25.1. Canada NGS-Based RNA-Sequencing Market Overview
  • 25.2. Canada NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America NGS-Based RNA-Sequencing Market

  • 26.1. South America NGS-Based RNA-Sequencing Market Overview
  • 26.2. South America NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil NGS-Based RNA-Sequencing Market

  • 27.1. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East NGS-Based RNA-Sequencing Market

  • 28.1. Middle East NGS-Based RNA-Sequencing Market Overview
  • 28.2. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa NGS-Based RNA-Sequencing Market

  • 29.1. Africa NGS-Based RNA-Sequencing Market Overview
  • 29.2. Africa NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. NGS-Based RNA-Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. NGS-Based RNA-Sequencing Market Competitive Landscape
  • 30.2. NGS-Based RNA-Sequencing Market Company Profiles
    • 30.2.1. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Oxford Nanopore Technologies Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. BGI Group Overview, Products and Services, Strategy and Financial Analysis

31. NGS-Based RNA-Sequencing Market Other Major And Innovative Companies

  • 31.1. QIAGEN N.V.
  • 31.2. PerkinElmer Inc.
  • 31.3. Eurofins Scientific SE
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. F. Hoffmann-La Roche Ltd.
  • 31.6. Hamilton Company
  • 31.7. Takara Bio Inc.
  • 31.8. Tecan Trading AG
  • 31.9. GENEWIZ Inc.
  • 31.10. Novogene Corporation
  • 31.11. Macrogen Inc.
  • 31.12. Zymo Research Corp.
  • 31.13. Lexogen GmbH
  • 31.14. Partek Incorporated
  • 31.15. GATC Biotech AG

32. Global NGS-Based RNA-Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The NGS-Based RNA-Sequencing Market

34. Recent Developments In The NGS-Based RNA-Sequencing Market

35. NGS-Based RNA-Sequencing Market High Potential Countries, Segments and Strategies

  • 35.1 NGS-Based RNA-Sequencing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 NGS-Based RNA-Sequencing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 NGS-Based RNA-Sequencing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer